Obese individuals are at a higher risk of developing several health issues including type-2 diabetes, heart disease, ...

Celltrion announced Tuesday that its biosimilars Stoboclo and Osenvelt, referencing bone disease treatments Prolia and Xgeva (denosumab), have received marketing approval from the US Food and Drug ...

Celltrion, a major Korean biopharmaceutical firm, said Tuesday that its two new biosimilars for bone disease treatment, Stoboclo and Osenvelt, have obtained approval from the United States.

Ixekizumab reduces erosion and increases backfill in the sacroiliac joints of patients with radiographic axial ...

Since you can’t see your bones aging, you should be proactive about preventing osteoporosis. Atrium Health’s Fracture ...

It fills in the gaps with new bone, which renews and strengthens the skeletal structure. In Paget’s disease, the balance ...

For patients with a rare genetic disorder that turns their muscles into bone, there is new hope. The disease is […] ...

Trial at the Johns Hopkins Kimmel Cancer Center and other centers finds reduced-intensity haploidentical bone marrow ...

Clinical research has long focused on ways to harness the actions of the immune system. From vaccines to immunotherapies, ...

People living with Paget’s are at increased risk of fractures, so identify and remove any tripping hazards in the home.

Researchers have shown that innate immune training, also known as trained immunity (TRIM), leads to aggravated bone loss in experimental models of periodontitis and inflammatory arthritis.

Milk is high in several nutrients, including protein, calcium, and vitamin B12. It may protect bone health, reduce disease ...